Claremont Creek Ventures

Total investments

81

Average round size

12M

Portfolio companies

34

Rounds per year

4.50

Lead investments

10

Follow on index

0.58

Exits

15

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareFinancial ServicesHealth CareHealth DiagnosticsEnterprise SoftwareGeneticsMedical DeviceMedicalEnergy

Summary

Claremont Creek Ventures is the famous VC, which was founded in 2005. The company was established in North America in United States. The main department of described VC is located in the Oakland.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DNAnexus, Zipline Medical, Project Frog. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are SaaS, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

This organization was formed by Nat Goldhaber. We also calculated 3 valuable employees in our database.

The top activity for fund was in 2012. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this Claremont Creek Ventures works on 12 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2015.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Claremont Creek Ventures, startups are often financed by Sequoia Capital, Allos Ventures, Labrador Ventures. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital, XSeed Capital, The Westly Group. In the next rounds fund is usually obtained by Sequoia Capital, Levensohn Venture Partners, Allos Ventures.

Show more

Investments analytics

Analytics

Total investments
81
Lead investments
10
Exits
15
Rounds per year
4.50
Follow on index
0.58
Investments by industry
  • Biotechnology (24)
  • Health Care (16)
  • Energy (13)
  • Software (13)
  • Genetics (12)
  • Show 91 more
Investments by region
  • United States (81)
Peak activity year
2012
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
31M
Group Appearance index
0.93
Avg. company exit year
9
Avg. multiplicator
0.80
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ecoATM 01 May 2012 Other Commercial Products, Electrical Equipment, Consumer Electronics, Waste Management, Recycling Early Stage Venture 17M United States, California, San Diego
Enboarder 20 Nov 2018 Internet, Software, Information Technology, Human Resources, SaaS, Employee Benefits Seed 2M New South Wales, Sydney, Australia
Natera 05 Dec 2008 Biotechnology, Health Diagnostics, Genetics, Medical Early Stage Venture 4M United States, California

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.